Financhill
Back

Black Diamond Therapeutics, Inc. Stock Price Chart

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
9

BDTX
Black Diamond Therapeutics, Inc.

Last Price:
$2.53
Seasonality Move:
-28.39%

7 Day Trial

ALL ACCESS PASS

$ 7
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing slight selling pressure.

Black Diamond Therapeutics, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 2.65 Sell
20-day SMA: 3.05 Sell
50-day SMA: 3.63 Sell
200-day SMA: 2.72 Sell
8-day EMA: 2.66 Sell
20-day EMA: 2.98 Sell
50-day EMA: 3.33 Sell
200-day EMA: 3.12 Sell

Black Diamond Therapeutics, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.34 Sell
Relative Strength Index (14 RSI): 27.92 Sell
Chaikin Money Flow: -53817 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.64 - 3.82) Sell
Bollinger Bands (100): (2.75 - 3.97) Sell

Black Diamond Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Black Diamond Therapeutics, Inc. Stock

Is Black Diamond Therapeutics, Inc. Stock a Buy?

BDTX Technical Analysis vs Fundamental Analysis

Sell
9
Black Diamond Therapeutics, Inc. (BDTX) is a Sell

Is Black Diamond Therapeutics, Inc. a Buy or a Sell?

Black Diamond Therapeutics, Inc. Stock Info

Market Cap:
144.7M
Price in USD:
2.54
Share Volume:
1.5M

Black Diamond Therapeutics, Inc. 52-Week Range

52-Week High:
4.94
52-Week Low:
1.20
Sell
9
Black Diamond Therapeutics, Inc. (BDTX) is a Sell

Black Diamond Therapeutics, Inc. Share Price Forecast

Is Black Diamond Therapeutics, Inc. Stock a Buy?

Fundamental Analysis of Black Diamond Therapeutics, Inc.

Is Black Diamond Therapeutics, Inc. a good investment?

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.69 per share, and a decrease next year of $1.02 per share.

Technical Analysis of Black Diamond Therapeutics, Inc.

Should I short Black Diamond Therapeutics, Inc. stock?

* Black Diamond Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.